Peggy Wallace - Jun 18, 2025 Form 4 Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role: Director
Signature: /s/ John Brendan Doyle, Attorney-in-Fact
Stock symbol: CGTX
Transactions as of: Jun 18, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/23/2025, 07:21 PM
Previous filing: Jun 11, 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Wallace Peggy	Director	C/O COGNITION THERAPEUTICS, INC., 2500 WESTCHESTER AVE, PURCHASE	/s/ John Brendan Doyle, Attorney-in-Fact	2025-06-23	0001876466

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CGTX	Common Stock	Award	$0	+34K	+64.81%	$0.00	86.5K	Jun 18, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 18, 2026 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.

Content

Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 18, 2026 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.